212 related articles for article (PubMed ID: 36011265)
1. A Rare
Kabbage M; Ben Aissa-Haj J; Othman H; Jaballah-Gabteni A; Laarayedh S; Elouej S; Medhioub M; Kettiti HT; Khsiba A; Mahmoudi M; BelFekih H; Maaloul A; Touinsi H; Hamzaoui L; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011265
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
3. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
[TBL] [Abstract][Full Text] [Related]
4. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
[TBL] [Abstract][Full Text] [Related]
5. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
[TBL] [Abstract][Full Text] [Related]
6. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing].
Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589
[No Abstract] [Full Text] [Related]
7. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
[TBL] [Abstract][Full Text] [Related]
8. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
[TBL] [Abstract][Full Text] [Related]
9. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X
Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149
[TBL] [Abstract][Full Text] [Related]
10. Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.
Fewings E; Larionov A; Redman J; Goldgraben MA; Scarth J; Richardson S; Brewer C; Davidson R; Ellis I; Evans DG; Halliday D; Izatt L; Marks P; McConnell V; Verbist L; Mayes R; Clark GR; Hadfield J; Chin SF; Teixeira MR; Giger OT; Hardwick R; di Pietro M; O'Donovan M; Pharoah P; Caldas C; Fitzgerald RC; Tischkowitz M
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):489-498. PubMed ID: 29706558
[TBL] [Abstract][Full Text] [Related]
11. Targeted next generation sequencing screening of Lynch syndrome in Tunisian population.
Ben Sghaier R; Jansen AML; Bdioui A; Van Wezel T; Ksiaa M; Elgolli L; Ben Fatma L; Ben Ahmed S; Azzouz MM; Hellara O; Elghali A; Darbel F; Skandrani K; Mokkni M; Gdissa A; Ltaief R; Saad A; Hmila F; Gribaa M; Morreau H
Fam Cancer; 2019 Jul; 18(3):343-348. PubMed ID: 31114938
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN
Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536
[TBL] [Abstract][Full Text] [Related]
14. A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance-functional analysis reveals the pathogenic one.
Kantelinen J; Hansen TV; Kansikas M; Krogh LN; Korhonen MK; Ollila S; Nyström M; Gerdes AM; Kariola R
Fam Cancer; 2011 Sep; 10(3):515-20. PubMed ID: 21431882
[TBL] [Abstract][Full Text] [Related]
15. Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals.
Valentin MD; da Silva FC; dos Santos EM; Lisboa BG; de Oliveira LP; Ferreira Fde O; Gomy I; Nakagawa WT; Aguiar Junior S; Redal M; Vaccaro C; Valle AD; Sarroca C; Carraro DM; Rossi BM
Fam Cancer; 2011 Dec; 10(4):641-7. PubMed ID: 21681552
[TBL] [Abstract][Full Text] [Related]
16. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
[TBL] [Abstract][Full Text] [Related]
17. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
18. Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients.
Zahary MN; Kaur G; Abu Hassan MR; Singh H; Naik VR; Ankathil R
World J Gastroenterol; 2012 Feb; 18(8):814-20. PubMed ID: 22371642
[TBL] [Abstract][Full Text] [Related]
19. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.
Mueller J; Gazzoli I; Bandipalliam P; Garber JE; Syngal S; Kolodner RD
Cancer Res; 2009 Sep; 69(17):7053-61. PubMed ID: 19690142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
